These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38333072)

  • 21. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes.
    Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X
    Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Number of positive preoperative biopsy cores is a predictor of positive surgical margins (PSM) in small prostates after robot-assisted radical prostatectomy (RARP).
    Tuliao PH; Koo KC; Komninos C; Chang CH; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2015 Dec; 116(6):897-904. PubMed ID: 25098818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan.
    Hashimoto T; Yoshioka K; Gondo T; Ozu C; Horiguchi Y; Namiki K; Ohno Y; Ohori M; Nakashima J; Tachibana M
    Int J Clin Oncol; 2014 Aug; 19(4):702-7. PubMed ID: 24048883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
    Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
    Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decipher Score predicts prostate specific antigen persistence after prostatectomy.
    Treacy PJ; Falagario UG; Magniez F; Ratnani P; Wajswol E; Martini A; Jambor I; Wiklund P; Bentellis I; Barthe F; Kyprianou N; Durand M; Steffens D; Karunaratne S; Leslie S; Thanigasalam R; Tewari A
    Minerva Urol Nephrol; 2023 Oct; 75(5):583-590. PubMed ID: 37728494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retzius-sparing Robot-assisted Radical Prostatectomy Leads to Durable Improvement in Urinary Function and Quality of Life Versus Standard Robot-assisted Radical Prostatectomy Without Compromise on Oncologic Efficacy: Single-surgeon Series and Step-by-step Guide.
    Egan J; Marhamati S; Carvalho FLF; Davis M; O'Neill J; Lee H; Lynch JH; Hankins RA; Hu JC; Kowalczyk KJ
    Eur Urol; 2021 Jun; 79(6):839-857. PubMed ID: 32536488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry.
    Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL
    BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancer.
    Sfoungaristos S; Perimenis P
    Can Urol Assoc J; 2012 Feb; 6(1):46-50. PubMed ID: 22396369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of unifocal and multifocal positive surgical margins in a large series of robot-assisted radical prostatectomy for prostate cancer.
    Keller EX; Bachofner J; Britschgi AJ; Saba K; Mortezavi A; Kaufmann B; Fankhauser CD; Wild P; Sulser T; Hermanns T; Eberli D; Poyet C
    World J Urol; 2019 Sep; 37(9):1837-1844. PubMed ID: 30519744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robot-assisted radical prostatectomy in the treatment of patients with clinically high-risk localized and locally advanced prostate cancer: single surgeons functional and oncologic outcomes.
    Shin TY; Lee YS
    BMC Urol; 2022 Apr; 22(1):49. PubMed ID: 35379195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes.
    de Carvalho PA; Barbosa JABA; Guglielmetti GB; Cordeiro MD; Rocco B; Nahas WC; Patel V; Coelho RF
    Eur Urol; 2020 May; 77(5):628-635. PubMed ID: 30041833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy.
    Peng C; Zhang J; Hou J
    Cancer Manag Res; 2019; 11():1133-1139. PubMed ID: 30774441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
    Sukumar S; Rogers CG; Trinh QD; Sammon J; Sood A; Stricker H; Peabody JO; Menon M; Diaz-Insua M
    BJU Int; 2014 Dec; 114(6):824-31. PubMed ID: 24053586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy for high-risk prostate cancer: a preoperative nomogram.
    Abdollah F; Klett DE; Sood A; Sammon JD; Pucheril D; Dalela D; Diaz M; Peabody JO; Trinh QD; Menon M
    BJU Int; 2015 Nov; 116(5):703-12. PubMed ID: 25413443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
    Ha YS; Kang DI; Kim JH; Joung JY; Yu J; Parihar JS; Salmasi AH; Horie S; Kim WJ; Yi Kim I
    Can J Urol; 2014 Jun; 21(3):7290-7. PubMed ID: 24978359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of Preoperative Prostate Health Index and Serum Testosterone Testing for Biochemical Recurrence after Radical Prostatectomy for Non-Metastatic Prostate Cancer.
    Zhang C; Zhang Y; Niu N; Fu G
    Arch Esp Urol; 2023 Dec; 76(10):787-795. PubMed ID: 38186072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.